Patent ID: 8841313

Claim:
A compound according to formula (I), wherein R 1 is -L 1 -R 6 , wherein L 1 is a linker selected from a bond or a group selected from among —C 1 -C 2 -alkylene, wherein R 6 is a ring selected from among —C 3 -C 8 -cycloalkyl, —C 3 -C 8 -heterocyclyl, -C 5 -C 10 -aryl, and -C 5 -C 10 -heteroaryl, wherein the ring R 6 is optionally substituted with one or more groups selected from among —CF 3 , —O—CF 3 , —CN, —C 1 -C 6 -alkyl, and -halogen, or wherein the ring R 6 is optionally substituted with one or more groups selected from among —C 1 -C 6 -alkyl, —O—C 1 -C 6 -alkyl, -C 5 -C 10 -aryl, -C 5 -C 10 -heteroaryl, —C 3 -C 8 -cycloalkyl, —C 3 -C 8 -heterocyclyl, —C 2 -C 6 -alkenyl, and —C 2 -C 6 -alkynyl, optionally being substituted by one or more groups selected from among —OH, —NH 2 , —C 1 -C 6 -alkyl, —O—C 1 -C 6 -alkyl, —CN, —CF 3 , —OCF 3 , halogen, and ═O; wherein R 2 is selected from among —H, —OCH 3 , —C 1 -C 3 -alkyl, and -cyclopropyl; wherein R 3 is selected from among —H, -methyl, -ethyl, -propyl, -i-propyl, -cyclopropyl, —OCH 3 , —CF 3 , and —CN; wherein R 4 is selected from among —H, and —C 1 -C 3 -alkyl; wherein R 5 is selected from among —H, —C 1 -C 4 -alkyl, —OH, —O—C 1 -C 4 -alkyl, -halogen, —CN, —CF 3 , and —OCF 3 ; wherein G and E are independently selected from among C or N; wherein n is 1, 2 or 3; as well as in form of their acid addition salts with pharmacologically acceptable acids.